BMJ (2020), Pg 368
Machine learning, artificial intelligence, and other modern statistical methods are providing new opportunities to operationalise previously untapped and rapidly growing sources of data for patient benefit. Despite much promising research currently being undertaken, particularly in imaging, the literature as a whole lacks transparency, clear reporting to facilitate replicability, exploration for potential ethical concerns, and clear demonstrations of effectiveness. Among the many reasons why these problems exist, one of the most important (for which we provide a preliminary solution here) is the current lack of best practice guidance specific to machine learning and artificial intelligence. However, we believe that interdisciplinary groups pursuing research and impact projects involving machine learning and artificial intelligence for health would benefit from explicitly addressing a series of questions concerning transparency, reproducibility, ethics, and effectiveness (TREE). The 20 critical questions proposed here provide a framework for research groups to inform the design, conduct, and reporting; for editors and peer reviewers to evaluate contributions to the literature; and for patients, clinicians and policy makers to critically appraise where new findings may deliver patient benefit.
CogStack information retrieval and extraction platform gives access to underused data
27 February 2023
CogStack represents a major advance in the capacity to extract and analyse unstructured data from electronic health records (EHRs). It uses a range of technologies to support modern open-source...
Biobank conversion allows greater UK contribution to international research
21 February 2023
A team of researchers processed and converted over 1.3 billion rows of UK Biobank data to the Observational Medical Outcomes Partnership (OMOP) common data model (CDM), improving its usability for...